Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference


Johnson & Johnson (NYSE: JNJ) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time)

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.


These press releases may also interest you

at 09:35
Firstsource Solutions Limited (NSE: FSL, BSE:532809), a global provider of Business Process Management (BPM) services and an RP-Sanjiv Goenka Group company, has acquired Quintessence Business Solutions & Services Private Limited, an India-based...

at 09:25
The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The China biological...

at 09:15
A new 90,000-square-foot expansion at 3M's facility in Valley, Nebraska, will increase the plant's manufacturing capacity and add new jobs to the community. ...

at 09:06
Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers...

at 09:05
NVIDIA's next-gen Blackwell platform, which includes B-series GPUs and integrates NVIDIA's own Grace Arm CPU in models such as the GB200, represents a significant development. TrendForce points out that the GB200 and its predecessor, the GH200, both...

at 09:05
Aditxt, Inc. ("Aditxt" or the "Company"), a company dedicated to discovering, developing, and deploying promising health innovations, today announced that it has entered into securities purchase agreements for the purchase and sale of an aggregate...



News published on and distributed by: